全文获取类型
收费全文 | 188220篇 |
免费 | 17941篇 |
国内免费 | 13286篇 |
专业分类
耳鼻咽喉 | 1576篇 |
儿科学 | 2157篇 |
妇产科学 | 1830篇 |
基础医学 | 18810篇 |
口腔科学 | 3609篇 |
临床医学 | 23736篇 |
内科学 | 24460篇 |
皮肤病学 | 1698篇 |
神经病学 | 8150篇 |
特种医学 | 7346篇 |
外国民族医学 | 78篇 |
外科学 | 19349篇 |
综合类 | 39955篇 |
现状与发展 | 43篇 |
一般理论 | 6篇 |
预防医学 | 14962篇 |
眼科学 | 4333篇 |
药学 | 20923篇 |
220篇 | |
中国医学 | 12663篇 |
肿瘤学 | 13543篇 |
出版年
2024年 | 728篇 |
2023年 | 2897篇 |
2022年 | 7178篇 |
2021年 | 8957篇 |
2020年 | 6960篇 |
2019年 | 5554篇 |
2018年 | 5715篇 |
2017年 | 5587篇 |
2016年 | 5218篇 |
2015年 | 8364篇 |
2014年 | 10468篇 |
2013年 | 10385篇 |
2012年 | 14830篇 |
2011年 | 16278篇 |
2010年 | 11719篇 |
2009年 | 9864篇 |
2008年 | 11400篇 |
2007年 | 11247篇 |
2006年 | 10710篇 |
2005年 | 9425篇 |
2004年 | 7208篇 |
2003年 | 7250篇 |
2002年 | 6087篇 |
2001年 | 4933篇 |
2000年 | 4027篇 |
1999年 | 3322篇 |
1998年 | 2006篇 |
1997年 | 2092篇 |
1996年 | 1542篇 |
1995年 | 1324篇 |
1994年 | 1182篇 |
1993年 | 719篇 |
1992年 | 799篇 |
1991年 | 692篇 |
1990年 | 616篇 |
1989年 | 508篇 |
1988年 | 401篇 |
1987年 | 363篇 |
1986年 | 300篇 |
1985年 | 201篇 |
1984年 | 126篇 |
1983年 | 82篇 |
1982年 | 49篇 |
1981年 | 60篇 |
1980年 | 30篇 |
1979年 | 43篇 |
1963年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的 探讨胰门板降低技术处理胰腺段胆总管巨大结石的应用价值。方法 回顾性分析上海交通大学医学院附属仁济医院近期收治的1 例利用胰门板降低技术取出胰腺段胆总管巨大结石的患者临床资料,并复习文献资料。结果 该例患者胰腺段胆总管内嵌顿一颗直径约2.5 cm质硬结石,纵行切开十二指肠上段胆总管前壁后采用液电碎石仪和取石钳难以碎石和取石,最终笔者首次利用胰门板降低技术显露胰腺段胆总管前壁后,继续纵行切开胰腺段胆总管才取出结石。术后经抗感染、补液等对症支持治疗痊愈出院,随访1 年半无结石复发和胆管狭窄。结论 胰门板降低技术可安全显露胰腺段胆总管,有助于取出胰腺段胆总管内嵌顿结石。 相似文献
2.
3.
4.
5.
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis 下载免费PDF全文
6.
Dan-Feng Xu Bing Wu Jin-Xin Wang Jian Yu Jian-Xin Xie 《World Journal of Clinical Cases》2021,9(5):1096-1102
BACKGROUNDGuillain-Barré syndrome (GBS) is a rare disorder that typically presents with ascending weakness, pain, paraesthesias, and numbness, which mimic the findings in lumbar spinal stenosis. Here, we report a case of severe lumbar spinal stenosis combined with GBS.CASE SUMMARYA 70-year-old man with a history of lumbar spinal stenosis presented to our emergency department with severe lower back pain and lower extremity numbness. Magnetic resonance imaging confirmed the diagnosis of severe lumbar spinal stenosis. However, his symptoms did not improve postoperatively and he developed dysphagia and upper extremity numbness. An electromyogram was performed. Based on his symptoms, physical examination, and electromyogram, he was diagnosed with GBS. After 5 d of intravenous immunoglobulin (0.4 g/kg/d for 5 d) therapy, he gained 4/5 of strength in his upper and lower extremities and denied paraesthesias. He had regained 5/5 of strength in his extremities when he was discharged and had no symptoms during follow-up.CONCLUSIONGBS should be considered in the differential diagnosis of spinal disorder, even though magnetic resonance imaging shows severe lumbar spinal stenosis. This case highlights the importance of a careful diagnosis when a patient has a history of a disease and comes to the hospital with the same or similar symptoms. 相似文献
7.
8.
9.
Gui-Qi Zhu Ke-Qing Shi Sha Huang Gui-Qian Huang Yi-Qian Lin Zhi-Rui Zhou Martin Braddock Yong-Ping Chen Ming-Hua Zheng 《Medicine》2015,94(11)
Major ursodeoxycholic acid (UDCA)-based therapies for primary biliary cirrhosis (PBC) include UDCA only, or combined with either methotrexate (MTX), corticosteroids (COT), colchicine (COC), or bezafibrate (BEF). As the optimum treatment regimen is unclear and warrants exploration, we aimed to compare these therapies in terms of patient mortality or liver transplantation (MOLT) and adverse events (AE).PubMed, the Cochrane Library, and Scopus were searched for randomized controlled trials up to August 31, 2014. We estimated the hazard ratios (HRs) for MOLT and odds ratios (ORs) for AE. A sensitivity analysis based on the dose of UDCA was also executed.Thirty-one eligible articles were included. Compared with COT plus UDCA, UDCA (HR 0.38, 95% confidence interval [CI] 0.09–1.39), BEF plus UDCA (HR 0.29, 95% CI 0.02–4.83), COC plus UDCA (HR 0.39, 95% CI 0.07–2.25), MTX plus UDCA (HR 0.28, 95% CI 0.05–1.63), or OBS (HR 0.49, 95% CI 0.11–2.01) all provided an increased risk of MOLT. With respect to drug AE profile, although not differing appreciably, BEF plus UDCA was associated with more AEs compared with UDCA (OR 3.16, 95% CI 0.59–20.67), COT plus UDCA (OR 2.27, 95% CI 0.15–33.36), COC plus UDCA (OR 1.00, 95% CI 0.09–12.16), MTX plus UDCA (OR 2.03, 95% CI 0.23–17.82), or OBS (OR 3.00, 95% CI 0.53–20.75). The results of sensitivity analyses were highly consistent with previous analyses.COT plus UDCA was the optimal UDCA-based regimen for both MOLT and AEs. BEF plus UDCA was most likely to cause AEs, whereas monotherapy with UDCA and coadministriation of COT plus UDCA appeared to be associated with the fewest AEs for PBC treatment. 相似文献
10.
A mixed‐method study of effects of a therapeutic play intervention for children on parental anxiety and parents' perceptions of the intervention 下载免费PDF全文